Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations.
Hereditární hemoragická teleangiektázie (syndrom Osler-Weber-Rendu) Díl I. Patofyziologie, klinické příznaky a doporučený skrínink cévních malformací.
arteriovenous malformation
arteriovenous malformations
hereditary haemorrhagic telangiectasia
hereditary hemorrhagic teleangiectasia
Journal
Vnitrni lekarstvi
ISSN: 0042-773X
Titre abrégé: Vnitr Lek
Pays: Czech Republic
ID NLM: 0413602
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
23
4
2022
pubmed:
1
1
2021
medline:
27
4
2022
Statut:
ppublish
Résumé
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation. Patients with HHT may have telangiectasias and later may develop arteriovenous malformations in various organs. Pacients suffer from many complications caused by the malformations and therefore by patients with HHT must by performed screening of this arteriovenous malformations. Optimal treatment of this malformations is best delivered throught a multidisciplinary approach. Farmacological treatment is described in next paper.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM